Cohance : About Us : Leadership : Sudhir Kumar Singh, PhD

Executive Leadership Team

Sudhir Kumar Singh, PhD

Chief Executive Officer
Dr-sudhir

Sudhir Kumar Singh, PhD

Chief Executive Officer

Appointed: 29 September 2023

Dr. Sudhir Kumar Singh is the Chief Executive Officer of the Company. A distinguished scientist and industry leader, he holds a PhD in Medicinal Chemistry from the Central Drug Research Institute, one of India’s premier research institutions. He completed his postdoctoral fellowship in the USA and served as a faculty member at Rutgers University, New Jersey.

With over three decades of experience in the pharmaceutical and biotech industry, Dr. Singh has held leadership roles including Chief Operating Officer at Aragen Life Sciences Ltd., where he led India’s largest Contract Development and Manufacturing Organization (CDMO) with a team of over 2,000 scientists. His strategic vision and deep expertise in drug discovery and development have consistently driven organizational growth and innovation.

A pioneer in his field, Dr. Singh has contributed significantly to the advancement of novel therapies through research excellence and patented innovations.

Dr. V. Prasada Raju was appointed Managing Director of Suven Pharmaceuticals on September 29, 2023. He also serves as the CEO and Managing Director of Cohance Lifesciences Ltd.Dr. Raju brings over three decades of comprehensive experience in the pharmaceutical industry, with strong credentials in strategy, operations, scientific affairs, and business development. Previously, he was Executive Director at Granules India Ltd, where he played a pivotal role in shaping growth strategy, managing the product pipeline, leading regulatory and intellectual property functions, and spearheading new business initiatives. He was also instrumental in setting up R&D and Greenfield manufacturing projects.
In his earlier roles, Dr. Raju served on the boards of several key entities, including Granules Omnichem Pvt. Ltd. (Vizag, India), Granules Pharmaceuticals Inc. (Washington, D.C., USA), and USpharma Ltd. (Florida, USA). He spent nearly two decades at Dr. Reddy’s Laboratories (1994–2012), holding senior positions with responsibilities spanning technical, strategic, and operational leadership. Dr. Raju holds a PhD in Chemistry and a Postgraduate Diploma in Patent Law, and has undergone specialized training in material sciences at IIT, Chicago, USA. He is also an alumnus of the Senior Management Program at the Indian Institute of Management, Calcutta (IIMC). Dr. Raju’s diverse expertise and leadership acumen position him as a highly respected figure in the pharmaceutical sector. Other Directorships / Full-time Positions in Body Corporates:
Name of the Company / Body Corporate
Cohance Lifesciences Limited
Position
Managing Director
Name of the Company / Body Corporate
Sapala Organics Private Limited
Position
Director
In his earlier roles, Dr. Raju served on the boards of several key entities, including Granules Omnichem Pvt. Ltd. (Vizag, India), Granules Pharmaceuticals Inc. (Washington, D.C., USA), and USpharma Ltd. (Florida, USA). He spent nearly two decades at Dr. Reddy’s Laboratories (1994–2012), holding senior positions with responsibilities spanning technical, strategic, and operational leadership. Dr. Raju holds a PhD in Chemistry and a Postgraduate Diploma in Patent Law, and has undergone specialized training in material sciences at IIT, Chicago, USA. He is also an alumnus of the Senior Management Program at the Indian Institute of Management, Calcutta (IIMC). Dr. Raju’s diverse expertise and leadership acumen position him as a highly respected figure in the pharmaceutical sector. Other Directorships / Full-time Positions in Body Corporates:
SI Name of the Company / Body Corporate Position
1 Cohance Lifesciences Limited Managing Director
2 Sapala Organics Private Limited Director